Evidence map›Paper›PMID 35418939›Full record

ArticleFrontiers in neurology2022

Evaluation of the Effectiveness of the Tap Test by Combining the Use of Functional Gait Assessment and Global Rating of Change.

Masahiro Kameda, Yoshinaga Kajimoto, Akihiro Kambara, Kohei Tsujino, Hironori Yamada, Fugen Takagi, Yusuke Fukuo, Takuya Kosaka, Takuya Kanemitsu, Yoshihide Katayama and 9 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Masahiro KamedaDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Yoshinaga KajimotoDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Akihiro KambaraDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Kohei TsujinoDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Hironori YamadaDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Fugen TakagiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Yusuke FukuoDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Takuya KosakaDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Takuya KanemitsuDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Yoshihide KatayamaDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Yuichiro TsujiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Ryokichi YagiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Ryo HiramatsuDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Naokado IkedaDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Naosuke NonoguchiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Motomasa FuruseDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Shinji KawabataDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Toshihiro TakamiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Masahiko WanibuchiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Osaka University of Pharmaceutical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although the tap test for patients with suspected idiopathic normal pressure hydrocephalus (iNPH) is still often performed as part of the preoperative evaluation, it is true that some studies have reported the limitations of the tap test, claiming that it does not provide the additional information for appropriate patient selection for surgery. We aimed to determine whether a better method of pre- and post-tap test assessment could lead to appropriate patient selection for shunting. Methods: We performed the tap test as part of the preoperative evaluation in all 40 patients who underwent lumboperitoneal shunt surgery for iNPH from April 2021 to September 2021. We retrospectively analyzed the patient data. We examined whether a comprehensive evaluation of the effect of the tap test using the Functional Gait Assessment (FGA) and Global Rating of Change (GRC) scales would identify a wider range of patients who would benefit from shunt surgery than the 3-m Timed Up and Go test (TUG) alone. Results: Assuming a prevalence of 1% for iNPH, the TUG had a sensitivity of 0.23, specificity of 0.71, positive likelihood ratio of 0.79, and negative likelihood ratio of 1.09. When improvement in either the FGA or the GRC was used as a criterion for the validity of the tap test, the sensitivity was 0.88, specificity was 0.17, positive likelihood ratio was 1.06, and negative likelihood ratio was 0.71. Conclusion: Improvement in either the FGA or the GRC is a more sensitive criterion for the effectiveness of the tap test for the gait aspect than the TUG. Since the negative likelihood ratio is lower than that for the TUG alone, it is more appropriate to exclude patients with neither FGA nor GRC improvement from surgical indications than to exclude surgical indications based on a negative TUG.

Indexed as

functional gait assessmentglobal rating of change scaleidiopathic normal pressure hydrocephalussensitivity and specificityTimed Up and Go test

Identifiers

PMID35418939
PMCPMC8995551
OpenAlexW4220747545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.